Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/11/24 17:23 | 10/11/24 | MYGN | Health | Diagn | In Vitro & In Vivo Diagnostic | Diaz Paul J | UT | DO | P,CEO | 2 | S | -745 | 24.83 | 0 | -30 | 977 | D | |||||||||||||||
9/12/24 16:09 | 9/11/24 | MYGN | Health | Diagn | In Vitro & In Vivo Diagnostic | Muzzey Dale | UT | O | Chief Sc | 1 | S | -55 | 26.17 | 0 | -2 | 108 | D | |||||||||||||||
9/9/24 17:48 | 9/9/24 | MYGN | Health | Diagn | In Vitro & In Vivo Diagnostic | Dreismann Heinrich | UT | D | 1 | S | -271 | 27.05 | 0 | -10 | 122 | D | ||||||||||||||||
9/4/24 19:38 | 9/3/24 | MYGN | Health | Diagn | In Vitro & In Vivo Diagnostic | Reitan Colleen F | UT | D | 1 | S | -1,286 | 27.95 | 0 | -46 | 43 | D | ||||||||||||||||
8/23/24 16:16 | 8/21/24 | MYGN | Health | Diagn | In Vitro & In Vivo Diagnostic | Ancona Margaret | UT | O | SVP,Chie | 1 | S | -321 | 27.82 | 0 | -12 | 79 | D | |||||||||||||||
8/20/24 16:38 | 8/19/24 | MYGN | Health | Diagn | In Vitro & In Vivo Diagnostic | Kumar Rashmi | UT | D | 1 | S | -210 | 28.01 | 0 | -8 | 77 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |